Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 636 participants.
Also called NCT07687186
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 636 participants
- Registry
-
NCT07687186
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07687186. Randomized; quadruple masking; primary purpose treatment. Start 2026-08-21 (actual); primary completion 2028-06-22 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
- Condition
- Heart Failure
- Intervention (Drug)
- Qishen Yiqi Dripping Pills 2 bags
- Intervention (Drug)
- Qishen Yiqi Dripping Pills placebo 2 bags
- Lead sponsor
- Tasly Pharmaceutical Group Co., Ltd
Record details
- Record id
cardio:ct-nct07687186- Content hash
f33ae3d7680ae34ae94e0caab7bf5e6099e86f0f685e1cf575127e170a9b8b14